Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13,233 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of Body Mass Index on Outcomes in the Edoxaban Versus Warfarin Therapy Groups in Patients Underwent Cardioversion of Atrial Fibrillation (from ENSURE-AF).
Lip GYH, Merino JL, Banach M, de Groot JR, Maier LS, Themistoclakis S, Boriani G, Jin J, Melino M, Winters SM, Goette A. Lip GYH, et al. Among authors: jin j. Am J Cardiol. 2019 Feb 15;123(4):592-597. doi: 10.1016/j.amjcard.2018.11.019. Epub 2018 Nov 24. Am J Cardiol. 2019. PMID: 30527775 Clinical Trial.
A prospective evaluation of edoxaban compared to warfarin in subjects undergoing cardioversion of atrial fibrillation: The EdoxabaN vs. warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE-AF) study.
Lip GY, Merino J, Ezekowitz M, Ellenbogen K, Zamoryakhin D, Lanz H, Jin J, Al-Saadi N, Mercuri M, Goette A. Lip GY, et al. Among authors: jin j. Am Heart J. 2015 May;169(5):597-604.e5. doi: 10.1016/j.ahj.2015.02.009. Epub 2015 Feb 21. Am Heart J. 2015. PMID: 25965706 Free article. Clinical Trial.
Edoxaban versus enoxaparin-warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial.
Goette A, Merino JL, Ezekowitz MD, Zamoryakhin D, Melino M, Jin J, Mercuri MF, Grosso MA, Fernandez V, Al-Saady N, Pelekh N, Merkely B, Zenin S, Kushnir M, Spinar J, Batushkin V, de Groot JR, Lip GY; ENSURE-AF investigators. Goette A, et al. Among authors: jin j. Lancet. 2016 Oct 22;388(10055):1995-2003. doi: 10.1016/S0140-6736(16)31474-X. Epub 2016 Aug 30. Lancet. 2016. PMID: 27590218 Clinical Trial.
Anticoagulation Control in Warfarin-Treated Patients Undergoing Cardioversion of Atrial Fibrillation (from the Edoxaban Versus Enoxaparin-Warfarin in Patients Undergoing Cardioversion of Atrial Fibrillation Trial).
Lip GYH, Al-Saady N, Jin J, Sun M, Melino M, Winters SM, Zamoryakhin D, Goette A. Lip GYH, et al. Among authors: jin j. Am J Cardiol. 2017 Sep 1;120(5):792-796. doi: 10.1016/j.amjcard.2017.06.005. Epub 2017 Jun 15. Am J Cardiol. 2017. PMID: 28709650 Free article. Clinical Trial.
Relation of Stroke and Bleeding Risk Profiles to Efficacy and Safety of Edoxaban for Cardioversion of Atrial Fibrillation (from the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation [ENSURE-AF] Study).
Lip GYH, Merino JL, Dan GA, Themistoclakis S, Ellenbogen KA, De Caterina R, Goudev A, Jin J, Melino M, Winters SM, Goette A. Lip GYH, et al. Among authors: jin j. Am J Cardiol. 2018 Jan 15;121(2):193-198. doi: 10.1016/j.amjcard.2017.10.008. Epub 2017 Nov 20. Am J Cardiol. 2018. PMID: 29169605 Free article. Clinical Trial.
Spontaneous conversion in patients with non-valvular atrial fibrillation planned for electrical cardioversion: A subanalysis of the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion Of Atrial Fibrillation (ENSURE-AF) trial.
Cohen AA, Heidbuchel H, Le Heuzey JY, De Caterina R, Merino JL, Jin J, Melino M, Winters SM, Goette A, Lip GYH. Cohen AA, et al. Among authors: jin j. Am Heart J. 2019 Mar;209:131-135. doi: 10.1016/j.ahj.2018.10.008. Epub 2018 Nov 22. Am Heart J. 2019. PMID: 30635112 Clinical Trial. No abstract available.
Determinants of left atrium thrombi in scheduled cardioversion: an ENSURE-AF study analysis.
Merino JL, Lip GYH, Heidbuchel H, Cohen AA, De Caterina R, de Groot JR, Ezekowitz MD, Le Heuzey JY, Themistoclakis S, Jin J, Melino M, Winters SM, Merkely B, Goette A. Merino JL, et al. Among authors: jin j. Europace. 2019 Nov 1;21(11):1633-1638. doi: 10.1093/europace/euz213. Europace. 2019. PMID: 31436835 Free PMC article. Clinical Trial.
Edoxaban versus warfarin in vitamin K antagonist experienced and naïve patients from the edoxaban versus warfarin in subjects undergoing cardioversion of atrial fibrillation (ENSURE-AF) randomised trial.
Kozieł M, Al-Saady N, Hjortshøj SP, Goudev A, Huber K, Cohen A, Jin J, Melino M, Winters SM, Goette A, Lip GYH. Kozieł M, et al. Among authors: jin j. Clin Res Cardiol. 2020 Aug;109(8):1018-1024. doi: 10.1007/s00392-019-01594-9. Epub 2020 Jan 8. Clin Res Cardiol. 2020. PMID: 31915996 Free PMC article. Clinical Trial.
13,233 results
You have reached the last available page of results. Please see the User Guide for more information.